James F. Tessmer, VP, Finance & Accounting at LEXICON PHARMACEUTICALS, INC. (LXRX), sold 33,824 shares at $6.90 ($234K) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Seasonal sale ($234k) by VP, Finance & Accounting — this insider has traded LXRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.90 | 10,912 | $75K | 32.2% |
| 2 | $6.90 | 10,912 | $75K | 32.2% |
| 3 | $6.93 | 12,000 | $83K | 35.6% |
| Total | $6.91 avg | 33,824 | $234K | 100% |
| Filing → |
| LXRX | SELL | 2016-06-08 | $23K | — | Filing → |
| LXRX | SELL | 2016-05-23 | $78K | — | Filing → |